ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CPHI China Pharma Holdings Inc

0.26
-0.0139 (-5.07%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 143,933
Bid Price
Ask Price
News -
Day High 0.27

Low
0.2561

52 Week Range

High
2.05

Day Low 0.2561
Share Name Share Symbol Market Stock Type
China Pharma Holdings Inc CPHI AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0139 -5.07% 0.26 18:38:43
Open Price Low Price High Price Close Price Previous Close
0.266 0.2561 0.27 0.2579 0.273899
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
357 143,933 US$ 0.26076 US$ 37,532 - 0.2561 - 2.05
Last Trade Type Quantity Price Currency
19:00:00 100 US$ 0.2579 USD

China Pharma Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.96M 11.40M - 7.03M -3.08M -0.27 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

China Pharma News

Date Time Source News Article
5/30/202415:05Edgar (US Regulatory)Form 8-K - Current report
5/15/202415:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202415:05Edgar (US Regulatory)Form 8-K - Current report
2/23/202415:05Edgar (US Regulatory)Form 8-K - Current report
2/23/202415:05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock..
2/14/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
2/08/202415:05Edgar (US Regulatory)Form 8-K - Current report
2/06/202415:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of..
1/26/202416:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
1/12/202415:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
1/12/202413:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
12/21/202315:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CPHI Message Board. Create One! See More Posts on CPHI Message Board See More Message Board Posts

Historical CPHI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2740.28690.25610.2698368223,791-0.014-5.11%
1 Month0.37840.410.25610.3176695763,139-0.1184-31.29%
3 Months0.390.440.25610.3253253466,510-0.13-33.33%
6 Months0.5250.6880.25610.44688641,077,264-0.265-50.48%
1 Year1.902.050.25610.65652811,611,568-1.64-86.32%
3 Years35.99548.500.25617.771,053,359-35.74-99.28%
5 Years14.32581.500.256120.921,218,336-14.07-98.18%

China Pharma Description

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Your Recent History

Delayed Upgrade Clock